tm logo
KINNATE
SEARCHED

on 19 Sep 2024

Last Applicant/ Owned by

KINNATE BIOPHARMA INC.

3611 Valley Centre Drive, Suite 175San Diego, California 92130

US

Serial Number

2078388 filed on 19th Jan 2021

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

KINNATE

Trademark usage description

therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; Read More

Classification Information


Class [005]
Therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; dermatological pharmaceutical preparations; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; antibacterial pharmaceuticals; pharmaceutical preparations for the prevention and treatment of allergies;


Classification kind code

11

Class [042]
Scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development;


Classification kind code

11

Mark Details


Serial Number

2078388

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 19th Sep 2024
Search Recorded
Submitted for opposition 20
on 19th Sep 2024
Examiner's First Report
Submitted for opposition 287
on 26th Apr 2022
Pre-Assessment Letter Sent
Submitted for opposition 135
on 11th Jan 2022
Amendment to Application
Submitted for opposition 30
on 19th Jan 2021
Filed
Submitted for opposition 1
on 19th Jan 2021
Created
Submitted for opposition 31
on 19th Jan 2021
Formalized